Background: A decline in memory is a hallmark of Alzheimer’s disease (AD). Experiments in rodents and post‐mortem studies in humans with AD suggest that serotonin (5‐HT) plays a role in memory, but the molecular and neural mechanisms mediating its effects are unknown.
Method: 100,000 individuals in UK Biobank were studied for the role of serotonin 2C receptor (5‐HTR) in the regulation of memory. We examined both wild‐type (WT) and transgenic mice (F327L) expressing a human loss‐of‐function serotonin 2C receptor (). Memory function was assessed using Radial Arm Water Maze test. Additionally, we conducted neural tracing by injecting retrograde viruses expressing GFP into the vCA1 of WT mice. We disrupted serotonin synthesis in vCA1‐projecting neurons using AAV‐Cre virus in mice and deleted 5‐HTRs on vCA1 neurons in mice. Furthermore, we evaluated the integrity of 5‐HT to vCA1 circuit using mice. Lastly, we explored the effects of lorcaserin, a selective 5‐HTR agonist, in mice.
Result: Our findings revealed that a rare loss‐of‐function mutation in significantly impaired short‐term memory in both humans and F327L mice. Neural tracing experiments demonstrated that midbrain serotonin neurons project to the vCA1 hippocampal region. Disruption of serotonin synthesis in vCA1‐projecting neurons and deletion of 5‐HTRs on vCA1 neurons led to memory impairment. Notably, the 5‐HT to vCA1 circuit was disrupted in mice. However, lorcaserin corrected memory loss in a mouse model of amyloid pathology.
Conclusion: The 5‐HT to vCA1 circuit regulates working memory. By utilizing 5‐HTR agonists, we can potentially bypass the damages in this circuit and enhance memory function in mice.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/alz.095039 | DOI Listing |
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11712326 | PMC |
J Dairy Sci
January 2025
Department of Animal and Dairy Sciences, University of Wisconsin-Madison, Madison, WI, 53701. Electronic address:
Inducing a transient state of hypocalcemia prepartum mobilizes stored calcium (Ca) before the abrupt demand for Ca at parturition thus more tightly regulating postpartum hypocalcemia. Prepartum transient hypocalcemia can be achieved through intravenous infusions of either the precursor to serotonin, 5-hydroxy-tryptophan (5HTP) or a Ca chelating agent, ethylene-glycol-tetraacetic acid (EGTA). This study aimed to compare the ability of 5HTP and EGTA treatments to prevent postpartum hypocalcemia.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Baylor College of Medicine, Houston, TX, USA
Background: A decline in memory is a hallmark of Alzheimer’s disease (AD). Experiments in rodents and post‐mortem studies in humans with AD suggest that serotonin (5‐HT) plays a role in memory, but the molecular and neural mechanisms mediating its effects are unknown.
Method: 100,000 individuals in UK Biobank were studied for the role of serotonin 2C receptor (5‐HTR) in the regulation of memory.
Alzheimers Dement
December 2024
Suven Life Sciences, Hyderabad, Telangana, India
Background: Alzheimer’s disease (AD) agitation is a distressing neuropsychiatric symptom characterized by excessive motor activity, verbal aggression, or physical aggression. Agitation is one of the causes of caregiver distress, increased morbidity and mortality, and early institutionalization in patients with AD. Current medications used for the management of agitation have modest efficacy and have substantial side effects.
View Article and Find Full Text PDFBackground: Seizures in Alzheimer’s Disease (AD) are increasingly recognized to occur and can increase cognitive decline and reduce survival compared to unaffected age‐matched peers ). Administration of antiseizure medicines (ASMs) to AD patients with epileptiform activity may improve cognition (), yet whether ASMs also beneficially confer long‐term survival benefits in AD is unknown. We have reported that young (presymptomatic) APP/PS1 mice exhibit enhanced chronic focal seizure susceptibility and premature seizure‐induced mortality, which is associated with dysregulated hippocampal serotonin system tone (5‐HT), altered neuroinflammation, and elevated soluble β‐amyloid (Aβ) levels (Del Pozo et al, 2024).
View Article and Find Full Text PDFDrug Metab Pharmacokinet
November 2024
Clinical Research, Drug Development Division, Sumitomo Pharma Co., Ltd., 33-94, Enoki-cho, Suita, Osaka, 564-0053, Japan. Electronic address:
The second-generation antipsychotic blonanserin is a highly selective, full antagonist of dopamine D and D and serotonin 5-HT receptors. It is currently prescribed for patients with schizophrenia in Japan. We aimed to develop a population pharmacokinetic model of oral blonanserin, including data from 12 to 77 years old patients, to assess the covariates that influence blonanserin pharmacokinetics and evaluate appropriate dosage regimens in adolescents versus adults.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!